Eliprodil
Eliprodil[edit | edit source]
Eliprodil is a pharmaceutical compound that acts as a non-competitive antagonist at the NMDA receptor, specifically targeting the NR2B subunit. It has been studied for its potential neuroprotective effects and its role in modulating glutamatergic neurotransmission.
Mechanism of Action[edit | edit source]
Eliprodil functions by inhibiting the activity of the NMDA receptor, a type of ionotropic glutamate receptor that plays a crucial role in synaptic plasticity and memory. By selectively binding to the NR2B subunit, Eliprodil reduces the influx of calcium ions into the neuron, which can help prevent excitotoxicity, a process that can lead to neuronal damage and cell death.
Pharmacological Effects[edit | edit source]
The primary pharmacological effect of Eliprodil is its neuroprotective capability. By modulating NMDA receptor activity, Eliprodil has been shown to reduce neuronal injury in various models of neurological disorders, including stroke and traumatic brain injury.
Clinical Applications[edit | edit source]
Although Eliprodil has demonstrated potential in preclinical studies, its clinical applications are still under investigation. Research has focused on its use in conditions such as ischemic stroke, where reducing excitotoxic damage could improve outcomes. However, further studies are needed to fully establish its efficacy and safety in humans.
Side Effects and Safety[edit | edit source]
As with many NMDA receptor antagonists, Eliprodil may have side effects related to its action on the central nervous system. These can include dizziness, nausea, and potential cognitive impairment. The safety profile of Eliprodil is still being evaluated in clinical trials.
Research and Development[edit | edit source]
Research into Eliprodil continues, with ongoing studies exploring its potential benefits and mechanisms of action. The compound's ability to selectively target the NR2B subunit makes it a promising candidate for further development in the treatment of neurodegenerative diseases.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
